What Intraoperative Fluence Parameters And Tissue Safety Endpoints Must Be Maintained During Ablative Laser Resurfacing? Key Settings To Avoid Scarring

During ablative laser resurfacing, there is no single universally safe fluence. Energy must be sufficient to ablate tissue efficiently, but the setting must be individualized by wavelength, pulse duration, spot size, scan pattern, treatment density, anatomic site, and skin type. The practical safety target is controlled ablation limited to the papillary or superficial upper reticular dermis, without excessive thermal accumulation or destruction of dermal appendages.

The operator should titrate fluence, density, and passes to a visible, controlled endpoint—not to a fixed numerical value alone. Stop when the intended dermal level is reached, particularly at early upper-reticular-dermis changes, because deeper treatment substantially increases the risk of scarring, prolonged erythema, pigmentary alteration, and delayed re-epithelialization.

How to Set and Maintain Fluence

Do not treat 5 J/cm² as a universal threshold

The reference value of 5 J/cm² should not be interpreted as a universal minimum or safe operating point for every CO₂ or Er:YAG device. Ablation depends on wavelength, pulse structure, tissue water content, beam diameter, dwell time, and the platform’s delivery mode.

Also, fluence is measured in J/cm², whereas irradiance is power density, generally expressed in W/cm². These are related but not interchangeable.

Use the device-specific ablation range

Fluence should be selected from the manufacturer’s validated clinical range and then adjusted according to the desired depth and the tissue response. The operator should document:

Fluence per microbeam or spot
Pulse duration and repetition rate
Spot size or beam diameter
Pass number
Treatment density or coverage
Overlap and scanning pattern

A high fluence with low density can produce a different injury pattern from a lower fluence with high density. Both must be considered when estimating total thermal burden.

Adjust for anatomy and skin characteristics

Thicker or more fibrotic regions may tolerate greater treatment intensity than delicate areas, but this does not mean that higher fluence and multiple passes are automatically required. The endpoint should determine whether additional treatment is justified.

Use particular caution with:

Periocular skin, because it is thin and anatomically vulnerable
Neck and chest, which have greater risks of prolonged erythema and hypertrophic scarring
Darker skin phototypes, particularly Fitzpatrick III and above, because of increased dyschromia and scarring risk
Previously scarred or inflamed tissue, which may respond unpredictably

Tissue Safety Endpoints

Target the papillary to superficial upper reticular dermis

The intended endpoint is controlled ablation into the papillary dermis or, when clinically indicated, the superficial upper reticular dermis. Deeper penetration risks destroying adnexal structures that support re-epithelialization and wound healing.

The operator should reassess the tissue after each pass rather than assuming that a preset number of passes is safe.

Recognize progressive visual changes

Color and surface changes provide useful—but not standalone—depth information. Depending on the laser and treatment depth, expected progression may include:

Transient epidermal whitening or yellow-brown change
Pink coloration at the epidermal–dermal junction
Pinpoint bleeding in the lower papillary dermis
Increasing transudate or more extensive bleeding near the upper reticular dermis

Splotchy bleeding, profuse transudate, or a distinct yellowish-white “chamois” appearance should be treated as a warning that the upper reticular dermis has been reached. Continuing beyond this stage can increase the risk of permanent scarring.

Interpret endpoints according to laser type

Er:YAG systems

Er:YAG lasers have high water absorption and generally produce less residual thermal necrosis. Possible endpoints progress from superficial whitening to pink tissue, pinpoint bleeding, and then more extensive bleeding or transudation at deeper levels.

Saline wiping between passes is often less important than with CO₂ systems, but the tissue should still be kept visible and free of debris.

CO₂ systems

CO₂ treatment produces more collateral thermal injury and leaves coagulated tissue debris after each pass. This whitish debris should be removed with saline-moistened gauze after every pass so that it does not act as an insulating heat sink and increase thermal injury.

The endpoint progresses toward a smooth pink papillary dermis, visible collagen changes, and then yellowish coloration at the upper reticular dermis. Treatment should stop before excessive whitening, charring, deep bleeding, or loss of normal tissue architecture.

Intraoperative Parameters Beyond Fluence

Limit stacking and overlap

Use a systematic grid with minimal beam overlap and avoid repeated firing over the same location. Motion-scanning handpieces can reduce accidental stacking, but the operator must still control speed, overlap, and passes.

Treatment should proceed in an organized pattern so that previously treated areas can be recognized and reassessed.

Control density and pass number

For fractional systems, density may be as important as fluence. Increasing coverage or repeating passes increases the total fraction of injured skin and the cumulative thermal load.

Lower density, fewer passes, or both are generally appropriate for:

Thin or sensitive areas
Neck and chest
Darker phototypes
Patients with a history of abnormal scarring or pigmentary change

Remove thermal debris with CO₂ treatment

With fully ablative or strongly thermal CO₂ treatment, saline-gauze wiping between passes is a key safety step. It improves visualization and removes residual coagulum that can retain heat.

Failure to clear debris can make the apparent endpoint misleading and promote deeper thermal injury.

Other Mandatory Tissue-Safety Controls

Protect the eyes

Use wavelength-appropriate external protection for facial treatment and internal metal ocular shields when treating eyelid skin. Shields should be inserted only after appropriate ophthalmic anesthetic and lubrication, with careful attention to correct positioning.

Control fire risk

Avoid flammable preparations and exposed oxygen near the laser field. Wet drapes or saline-moistened gauze should protect adjacent hair, towels, airway devices, and other combustible materials.

Alcohol-containing preparations must be fully removed and allowed to dry before firing.

Evacuate the plume

Ablative resurfacing generates aerosolized tissue and potentially biohazardous plume. Continuous use of a dedicated high-efficiency smoke evacuator and appropriate respiratory protection is required.

Monitor the wound throughout the procedure

The operator should repeatedly assess:

Color and surface texture
Bleeding pattern
Transudate
Evidence of charring
Unexpectedly deep or confluent injury
Excessive pain or heat
Symmetry between treated regions

A test spot can help evaluate inflammatory and pigmentary response, particularly when treating patients at higher risk of dyschromia.

Understanding the Trade-offs

Higher fluence is not automatically better

Higher energy may improve ablation efficiency or treatment depth, but it also increases thermal injury and the likelihood of scarring, persistent erythema, and pigmentary complications.

The goal is adequate ablation with the lowest cumulative thermal burden that achieves the clinical objective.

More passes can create hidden injury

Even when each pass appears acceptable, repeated passes can stack energy in the same tissue. This is especially hazardous in thin skin, at high density, or when debris obscures the true endpoint.

Visual endpoints are not perfectly precise

Skin color varies with baseline pigmentation, vascularity, bleeding, and illumination. Endpoint assessment must therefore be combined with device knowledge, treatment mapping, conservative pass selection, and continuous reassessment.

Applying the Parameters Safely

The correct protocol is the one that matches the treatment goal while preserving viable dermal wound-healing structures.

If your primary focus is controlled ablation: Use device-specific fluence and pulse settings, limit overlap and passes, and stop at the intended papillary or superficial upper-reticular-dermis endpoint.
If your primary focus is minimizing complications: Reduce fluence, density, or passes in thin, extra-facial, or darker-pigmented areas and stop at early signs of excessive thermal injury.
If your primary focus is CO₂ safety: Wipe coagulated debris away after every pass, monitor for progressive yellow-white change or charring, and avoid continued treatment once the upper reticular dermis is reached.
If your primary focus is fractional resurfacing: Treat fluence, microbeam density, scan pattern, and overlap as a combined thermal dose rather than optimizing fluence alone.
If your primary focus is procedural safety: Maintain wavelength-specific eye protection, continuous plume evacuation, and strict fire prevention throughout the procedure.

Safe ablative resurfacing depends on disciplined control of cumulative thermal injury and recognition of the tissue endpoint—not on achieving a preset fluence in isolation.

Summary Table:

Parameter	Key Points
Fluence	Individualize per device, not universal 5 J/cm²; adjust per spot size, pulse, density.
Endpoint	Controlled ablation to papillary or superficial upper reticular dermis; stop at chamois appearance.
Passes	Limit overlap and stacking; reassess after each pass.
Debris Removal	For CO₂, wipe with saline between passes to prevent heat buildup.
Safety	Eye protection, smoke evacuation, fire prevention.

Ensure your practice delivers safe and effective ablative laser treatments with BELIS's advanced aesthetic devices, including CO₂ fractional and Er:YAG systems. Our equipment is designed for precision and patient safety. Contact us today to learn more about how BELIS can elevate your clinic's standards and patient outcomes. Get in touch with our experts.